Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.
Prenosis has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Prenosis's investors include National Science Foundation, UC Investments, Global Health Investment Corporation, LabCorp Venture Fund, PACE Healthcare Capital.
Prenosis is headquartered in Chicago, United States.
Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions.
Prenosis is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Prenosis — Funding & Investors." VCBacked, January 29, 2026, https://www.vcbacked.co/company/prenosis. Accessed July 25, 2026.
VCBacked. (2026). Prenosis — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/prenosis
{{cite web |title=Prenosis — Funding & Investors |url=https://www.vcbacked.co/company/prenosis |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated